Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Epidemiology. 2020 May;31(3):402–408. doi: 10.1097/EDE.0000000000001175

Table 1.

Numbers of cases and controls included in analysis by study

Study Name Geographic Location Study Period Controls Cases Serous Mucinous Endometrioid Clear cell
Disease of the Ovary and their Evaluation Study 12 Washington 2002–2009 495 285 171 7 41 25
Hawaii Ovarian Cancer Study 11 Hawaii 1994–2007 106 90 45 7 10 6
Hormones and Ovarian Cancer Prediction 14a Western Pennsylvania, Northeast Ohio, Western New York 2003–2008 594 253 167 8 26 17
New England Case-Control Study of Ovarian Cancer 13 New Hampshire, Eastern Massachusetts 1999–2008 362 286 183 16 47 16
University of Southern California, Study of Lifestyle and Women’s Health 9a Los Angeles, California 1993–2005 738 595 354 37 56 41
Total: 2295 1509 920 b 75 b 180 b 105 b
a

Some of the study’s primary data were included in the Collaborative Group’s analysis 8.

b

Sum of numbers do not equal total number of cases because some cases were not classified as one of the four histotypes considered.